- £822.95m
- £1.01bn
- $713.40m
- 77
- 47
- 97
- 88
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 874 | 751 | 709 | 736 | 713 |
Cost of Revenue | |||||
Gross Profit | 321 | 257 | 289 | 299 | 284 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 773 | 780 | 698 | 778 | 655 |
Operating Profit | 101 | -28.2 | 11.9 | -41.8 | 58.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 61 | -68.8 | -7.5 | -54.8 | 39.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 46.4 | -67 | -7.1 | -62.6 | 28.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 46.4 | -67 | 3.3 | -51.1 | 26.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 46.5 | -67 | 2.5 | -51.1 | 26.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.111 | 0.017 | 0.127 | 0.126 | 0.115 |
Dividends per Share |